FRL2 and FRL3 are able to form hetero-oligomers. A, FRL2N
and FRL3N form hetero-oligomers in vivo. FLAG-tagged FRL3N, or FRL2N,
was co-expressed in NIH 3T3 cells with Myc-tagged FRL3N or FRL2N. FLAG-tagged
FRL3N efficiently co-immunoprecipitated (IP) FRL3N and FRL2N (compare
lanes 1 and 2 with lanes 3 and 4 and
lanes 5 and 6 with lanes 7 and 8).
FLAG-tagged FRL2N efficiently co-immunoprecipitated FRL2N. FLAG beads alone
served as a negative control (lanes 1 and 2 and lanes
5 and 6). B, FRL2.FH2 and FRL3.FH2 form
hetero-oligomers in vivo. FLAG-tagged FRL3.FH2 or FRL2.FH2 was
co-expressed in NIH 3T3 cells with Myc-tagged FRL2.FH2 and FRL3.FH2.
FLAG-tagged FRL3.FH2 efficiently co-immunoprecipitated FRL2.FH2 and FRL3.FH2
(compare lanes 1 and 2 with lanes 3 and 4
and lanes 9 and 10). FLAG-tagged FRL2.FH2 also efficiently
co-immunoprecipitated FRL2.FH2 and FRL3.FH2 (compare lanes 5 and
6 with lanes 7 and 8 and lanes 11 and
12). FLAG beads alone served as a negative control (lanes
9-12). Vertical lines separate different exposures of the same
immunoblot (lanes 1, 2, 5, 6, and 9-12 versus lanes 3, 4, 7,
and 8). C, full-length FRL2 and FRL3 form hetero-oligomers
in vivo. FLAG-tagged FRL3 or FRL2 was co-expressed in NIH 3T3 cells
with Myc-tagged FRL2 and FRL3. FLAG-tagged FRL3 efficiently
co-immunoprecipitated FRL3 and FRL2 (compare lanes 1 and 2
with lanes 3 and 4 and lanes 9 and 10).
FLAG-tagged FRL2 also efficiently co-immunoprecipitated FRL2 and FRL3 (compare
lanes 5 and 6 with lanes 7 and 8 and
lanes 11 and 12). FLAG beads alone served as a negative
control (lanes 9-12).